Silke Duensing-Kropp

 

 

Publications

Knümann, L.; Rodriguez-Paniagua, A.; Reynders, M.; Duensing-Kropp, S.; Thorn-Seshold, O.; Morozov, V.; Marschner, J.A.; Merk, D. Dosing PPARγ Activation With Light Using Fast Relaxing Photoswitches. Angew. Chem. Int. Ed., 2026 DOI

Stiller, T.; Duensing-Kropp, S.; Marschner, J.A., Merk, D. Fragment-based discovery of dual ligand pharmacophores for lipid-sensing transcription factors for designed polypharmacology. RSC Med. Chem., 2025 DOI

Schallmayer, E.; Morozov, V.; Duensing-Kropp, S.; Schallmayer, L.; Schüffner, L.; Schubert-Zsilavecz, M.; Pabel, J.; Höfner, G.; Heering, J.; Marschner, J.A.; Merk, D. A First-in-Class Hepatocyte Nuclear Factor 4 Agonist. J. Med. Chem., 2025 DOI

Zaienne, D.; Isigkeit, L.; Marschner, J.; Duensing-Kropp, S.; Höfner, G.; Merk, D. Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism. ChemMedChem, 2023, 18, e202300404 DOI 

Willems, S.; Marschner, J.; Kilu, W.; Faudone, G.; Busch, R.; Duensing-Kropp, S.; Heering, J.; Merk, D. Nurr1 modulation mediates neuroprotective effects of statins. Adv. Sci., 2022, 9(18), 2104640. DOI